Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peifen Fu

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Clinical and Experimental Medicine|April 7, 2021
Research on correlations of miR-585 expression with progression and prognosis of triple-negative breast cancerMinya Yao, Shuqian Wang, Luyan Chen, et al.
Frontiers in Oncology|November 16, 2020
Integrated Analysis of Distant Metastasis-Associated Genes and Potential Drugs in Colon AdenocarcinomaMiaowei Wu, Weiyang Lou, Meng Lou, et al.
Molecular Therapy. Nucleic Acids|August 19, 2020
RP11-480I12.5-004 Promotes Growth and Tumorigenesis of Breast Cancer by Relieving miR-29c-3p-Mediated AKT3 and CDK6 DegradationWeiyang Lou, Bisha Ding, Guansheng Zhong, et al.
Oncology Reports|April 17, 2014
Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1α downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell linesPeifen Fu, Feiya Du, Wei Chen, et al.
Breast Cancer (Tokyo, Japan)|March 19, 2014
EIF5A2 is a novel chemoresistance gene in breast cancerYu Liu, Feiya Du, Wei Chen, et al.
Experimental Cell Research|September 10, 2013
Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicinYu Liu, Feiya Du, Wei Chen, et al.
Aging|December 4, 2019
Dysregulation of pseudogene/lncRNA-hsa-miR-363-3p-SPOCK2 pathway fuels stage progression of ovarian cancerWeiyang Lou, Bisha Ding, Guansheng Zhong, et al.
Epigenomics|September 11, 2019
Identification of novel mRNA-miRNA-lncRNA competing endogenous RNA network associated with prognosis of breast cancerGuansheng Zhong, Weiyang Lou, Minya Yao, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 18, 2016
Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cellsYao-Min Chen, Yu Liu, Hai-Yan Wei, et al.
Frontiers in Oncology|December 19, 2022
Contrast-enhanced ultrasonography for early prediction of response of neoadjuvant chemotherapy in breast cancerJiabao Guo, Bao-Hua Wang, Mengna He, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Clinical and Experimental Medicine|April 7, 2021
Research on correlations of miR-585 expression with progression and prognosis of triple-negative breast cancerMinya Yao, Shuqian Wang, Luyan Chen, et al.
Frontiers in Oncology|November 16, 2020
Integrated Analysis of Distant Metastasis-Associated Genes and Potential Drugs in Colon AdenocarcinomaMiaowei Wu, Weiyang Lou, Meng Lou, et al.
Molecular Therapy. Nucleic Acids|August 19, 2020
RP11-480I12.5-004 Promotes Growth and Tumorigenesis of Breast Cancer by Relieving miR-29c-3p-Mediated AKT3 and CDK6 DegradationWeiyang Lou, Bisha Ding, Guansheng Zhong, et al.
Oncology Reports|April 17, 2014
Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1α downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell linesPeifen Fu, Feiya Du, Wei Chen, et al.
Breast Cancer (Tokyo, Japan)|March 19, 2014
EIF5A2 is a novel chemoresistance gene in breast cancerYu Liu, Feiya Du, Wei Chen, et al.
Experimental Cell Research|September 10, 2013
Knockdown of dual specificity phosphatase 4 enhances the chemosensitivity of MCF-7 and MCF-7/ADR breast cancer cells to doxorubicinYu Liu, Feiya Du, Wei Chen, et al.
Aging|December 4, 2019
Dysregulation of pseudogene/lncRNA-hsa-miR-363-3p-SPOCK2 pathway fuels stage progression of ovarian cancerWeiyang Lou, Bisha Ding, Guansheng Zhong, et al.
Epigenomics|September 11, 2019
Identification of novel mRNA-miRNA-lncRNA competing endogenous RNA network associated with prognosis of breast cancerGuansheng Zhong, Weiyang Lou, Minya Yao, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 18, 2016
Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cellsYao-Min Chen, Yu Liu, Hai-Yan Wei, et al.
Frontiers in Oncology|December 19, 2022
Contrast-enhanced ultrasonography for early prediction of response of neoadjuvant chemotherapy in breast cancerJiabao Guo, Bao-Hua Wang, Mengna He, et al.
Pageof 8